Every year, millions search for a finasteride alternative. The August 2025 EMA ruling formally confirmed suicidal ideation as a side effect of 1mg finasteride — the dose prescribed for hair loss. But the deeper issue is what finasteride has never addressed: the scalp ecosystem. This is the complete 2026 clinical guide to botanical 5-alpha reductase inhibition, scalp microbiome science, and the Dermotricology protocol that restores what DHT blockers leave completely untreated.

Hair loss is not a single condition — it is dozens of distinct disorders, each with a different biological mechanism, a different progression rate, and a critically different clinical response. Whether you are experiencing sudden diffuse shedding after a stressful event, gradual thinning at the crown driven by DHT, dandruff-driven scalp inflammation accelerating pattern loss, or the early warning signs of a scarring alopecia — the treatment that works for one condition does nothing for another, and the wrong treatment can make a reversible condition permanent. This guide gives you the clinical framework Dermotricology uses to identify which type of hair loss you have, whether your follicles are still recoverable, and the exact protocols that address each condition at the cellular level — not just the surface.